Endothelial dysfunction in diabetes

Stitt, A. W.
March 2014
Proceedings of the Physiological Society;2014, p53P
Conference Proceeding
An abstract of the article "Endothelial dysfunction in diabetes" by A. W. Stitt is presented.


Related Articles

  • Diabetic Retinopathy. Gómez-Ulla, Francisco // Current Diabetes Reviews;2009, Vol. 5 Issue 1, p1 

    The article discusses various reports published within the issue, including one by Monica Rodriguez-Fontal et al on the importance of metabolic control in managing diabetic retinopathy, one by Talia N. Crawford et al on the role of angiogenic factors in diabetic retinopathy and another one by...

  • Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications. Akiyode, Oluwaranti; Tran, Christine // Diabetes Spectrum;Winter2016, Vol. 29 Issue 1, p44 

    The article discusses the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents in the management of diabetic eye complications. Topics covered include the results of trials on the use of ranibizumab in people with diabetic macular edema (DME), the comparison of the...

  • Adenosine A2B receptor-mediated VEGF induction promotes diabetic glomerulopathy. Cárdenas, Angel; Toledo, Camilo; Oyarzún, Carlos; Sepúlveda, Angélica; Quezada, Claudia; Guillén-Gómez, Elena; Díaz-Encarnación, Montserrat M; Pastor-Anglada, Marçal; San Martín, Rody // Laboratory Investigation (00236837);Jan2013, Vol. 93 Issue 1, p135 

    Diabetic nephropathy ranks as the most devastating kidney disease worldwide. It characterizes in the early onset by glomerular hypertrophy, hyperfiltration and mesangial expansion. Experimental models show that overproduction of vascular endothelial growth factor (VEGF) is a pathogenic condition...

  • Evaluation of Antiangiogenic Effect of the Leaves of Justicia gendarussa (Burm. f) (Acanthaceae) by Chrio Allontoic Membrane Method. Periyanayagam, K.; Umamaheswari, B.; Suseela, L.; Padmini, M.; Ismail, M. // American Journal of Infectious Diseases;2009, Vol. 5 Issue 3, p180 

    Problem statement: Angiogenesis involves the formation of new blood vessels from preexisting blood vessels plays a crucial role in pathological processes such as diabetic retinopathy, arthritis and in the growth of solid tumors. Numerous reports had pointed out to the crucial role of...

  • Increased levels of vascular endothelial growth factor in aqueous humor of patients with diabetic retinopathy: Is it the whole truth? Gopal, K. S. Santhan // Indian Journal of Ophthalmology;Sep2011, Vol. 59 Issue 5, p405 

    A letter to the editor is presented in response to the article "Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy," by K. M. Selim and colleagues in the 2010 issue.

  • Anti-Vascular Endothelial Growth Factor Drugs for Diabetic Retinopathy. Forte, Raimondo; Querques, Giuseppe; Cennamo, Gilda; Bonavolontà, Paola; Pascotto, Arduino; Souied, Eric H // Current Medical Literature: Ophthalmology;2011, Vol. 21 Issue 2, p49 

    The article discloses the medical treatments for diabetic retinopathy, which all have the anti-vascular endothelial growth factor (VEGF). The disease is the third main cause of blindness in Western and developed nations after age-related macular degeneration (AMD) and glaucoma. Patients with...

  • Role of Cytokines and Trophic Factors in the Pathogenesis of Diabetic Retinopathy. Mitamura, Yoshinori; Harada, Chikako; Harada, Takayuki // Current Diabetes Reviews;2005, Vol. 1 Issue 1, p73 

    Diabetic retinopathy (DR) is one of the most frequent complications of diabetes and the leading cause of acquired blindness in developed countries. A note worthy problem in DR is the formation of fibrovascular epiretinal membranes (ERMs) which can cause tractional retinal detachment in the...

  • Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy. Ziyadeh, Fuad N.; Wolf, Gunter // Current Diabetes Reviews;2008, Vol. 4 Issue 1, p39 

    Microalbuminuria is the earliest detectable clinical abnormality in diabetic glomerulopathy. On a molecular level, metabolic pathways activated by hyperglycemia, glycated proteins, hemodynamic factors, and oxidative stress are key players in the genesis of diabetic kidney disease. A variety of...

  • Erythropoietin Is Highly Elevated in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy. Katsura, Yoshiya; Okano, Tadashi; Matsuno, Kazuhisa; Osako, Masahiro; Kure, Masahiko; Watanabe, Toshiya; Iwaki, Yoshiki; Noritake, Masayuki; Kosano, Hiroshi; Nishigori, Hideo; Matsuoka, Takeshi // Diabetes Care;Sep2005, Vol. 28 Issue 9, p2252 

    Presents a study that investigated the level of erythropoietin (EPO) in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR). Symptoms of PDR; Outcome of the measurement of concentrations of vascular endothelial growth factor from vitreous fluid samples taken from PDR...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics